BiotechTube
Home/Noveeda/Rob Chisholm
RC

Rob Chisholm

CEO

Noveeda

Therapeutic Areas

Allergy & ImmunologyToxicologyNeurologyEndocrinology

Noveeda Pipeline

DrugIndicationPhase
NasefrinAnaphylaxisPreclinical
NVE-02PoisoningPreclinical
NVE-03Breakthrough SeizuresPreclinical
NVE-04HypoglycaemiaPreclinical

Leadership Team at Noveeda

DJ
Dr. Josef Masek
Chief Scientific Officer
DP
Dr. Peter Loudon
Head of Clinical Development
View full Noveeda profile